Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amneal Plans ‘Meaningful Additions’ To Its Generics Portfolio
As Company Sees Increase In Its Generics Sales And Overall Revenues
Amneal expects to file 25 to 30 ANDAs and launch 20 to 30 new products on an annual basis • Source: Alamy
More from Generics
More from Products